Zolpidem 10 mg apo
Zolpidem 10 mg apo Logo 10 MG (Zolpidem Tartrate 10 mg) Pill with imprint Logo 10 MG is Yellow, Capsule-shape and has been identified as Zolpidem Tartrate 10 mg. It is supplied by APO. Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics.
Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 10 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
what is Zolpidem 10 mg apo
Zolpidem 10 mg apo (zolpidem tartrate ODT) is indicated for the short-term treatment and symptomatic relief of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings and/or early morning awakenings.
Geriatrics (≥ 65 years of age):
Elderly patients are especially susceptible to dose-related adverse effects, such as drowsiness, dizziness, or impaired coordination. Inappropriate, heavy sedation may result in accidental events/falls. Mean Cmax, T1/2 , and AUC were significantly increased in elderly subjects when.
Pediatrics (< 18 years of age):
Safety and effectiveness of zolpidem in pediatric patients under the age of 18 years have notbeen established. Therefore, zolpidem is not recommended for use in this population.
DOSAGE AND ADMINISTRATION
As with all hypnotics, long-term use of APO-ZOLPIDEM ODT is not recommended. Treatment with APO-ZOLPIDEM ODT (zolpidem tartrate ODT) should usually not exceed 7-10 consecutive days. Use for more than 2-3 consecutive weeks requires complete re-evaluation of the patient.
Use the lowest effective dose of APO-ZOLPIDEM ODT (zolpidem tartrate ODT) for the patient. The effect of APO-ZOLPIDEM ODT may be slowed by ingestion with or immediately after a meal. For earlier sleep onset, APO-ZOLPIDEM ODT should not be given with or immediately after a meal.